Sex difference in risk of torsade de pointes with d,l-sotalol

Circulation

Volumn 94, Issue 10, 1996, Pages 2534-2541

  Lehmann, Michael H ^a   Hardy, Sterling ^b   Archibald, Donald ^b   Quart, Barry ^b   MacNeil, Daniel J ^b  

^a SINAI GRACE HOSPITAL   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

antiarrhythmia agents; death, sudden; sex; torsade de pointes; women

Indexed keywords

CREATININE; SOTALOL; ANTIARRHYTHMIC AGENT;

ADULT; AGE; AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; ELECTROCARDIOGRAPHY; FEMALE; HEART ARREST; HEART RATE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QT INTERVAL; RISK FACTOR; SEX DIFFERENCE; TORSADE DES POINTES; AGING; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; INFORMATION SYSTEM; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY; REGRESSION ANALYSIS; SEX RATIO; SEXUAL DEVELOPMENT; TIME;

ADULT; AGED; AGING; ANTI-ARRHYTHMIA AGENTS; FEMALE; HEART RATE; HUMANS; INFORMATION SYSTEMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK FACTORS; SEX CHARACTERISTICS; SEX DISTRIBUTION; SOTALOL; TIME FACTORS; TORSADES DE POINTES;

EID: 0030588699     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.94.10.2535     Document Type: Article

References (36)

1. Singh BN. Electrophysiologic basis for the antiarrhythmic actions of sotalol and comparison with other agents. Am J Cardiol. 1993;72:8A-18A.
2. Roden DM. Usefulness of sotalol for life-threatening ventricular arrhythmias. Am J Cardiol. 1993;72:51A-55A.
3. Camm AJ, Paul V. Sotalol for paroxysmal supraventricular tachycardias. Am J Cardiol. 1990;65:67A-73A.
4. Mason JW, Electrophysiologic Study vs. Electrocardiographic Monitoring Investigators. A comparison of seven anti arrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med. 1993;329:452-458.
5. Smith WM, Gallagher JJ. 'Les torsades de pointes': an unusual ventricular arrhythmia. Ann Intern Med. 1980;93:578-584.
6. Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M, Lazzara R. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis. 1988;31:115-172.
7. Patterson E, Szabo B, Scherlag BJ, Lazzara R. Arrhythmogenic effects of antiarrhythmic drugs. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1995:496-511.
8. Kuck KH, Kunze KP, Roewer N, Bleifeld W. Sotalol-induced torsade de pointes. Am Heart J. 1984;107:179-180.
9. Arstall MA, Hii JTY, Lehman RG, Horowitz JD. Sotalol-induced torsade de pointes: management with magnesium infusion. Postgrad Med J. 1992;68:289-290.
10. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA. 1993;270:2590-2597.
11. MacNeil DJ, Davies RO, Deitchman D. Clinical safety profile of sotalol in the treatment of arrhythmias. Am J Cardiol. 1993;72:44A-50A.
12. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart. 1920;7:353-357.
13. Kay GN, Plumb VJ, Arciniegas JG, Henthorn RW, Waldo AL. Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients. J Am Coll Cardiol. 1983;2:806-817.
14. Bauman JL, Bauernfeind RA, Hoff JV, Strasberg B, Swiryn S, Rosen KM. Torsade de pointes due to quinidine: observations in 31 patients. Am Heart J. 1984;107:425-430.
15. Hanyok JJ. Clinical pharmacokinetics of sotalol. Am J Cardiol. 1993;72:19A-26A.
16. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
17. Betapace drug package insert. Berlex Laboratories, 300 Fairfield Rd, Wayne, NJ 07470-7358
18. Moss AJ, Robinson J. Clinical features of the idiopathic long QT syndrome. Circulation. 1992;85(suppl I):I-140-I-144.
19. Keating M. Linkage analysis and long QT syndrome: using genetics to study cardiovascular disease. Circulation. 1992;85:1973-1986.
20. Zareba W, Moss AJ, and the LQTS Study Group. Criteria for delayed repolarization in patients with wide QRS complex. J Am Coll Cardiol. 1994;37A. Abstract.
21. Wang T, Bergstrand RH, Thompson KA, Siddoway LA, Duff HJ, Woolsley RL, Roden DM. Concentration-dependent pharmacologic properties of sotalol. Am J Cardiol. 1986;57:1160-1165.
22. Hallynck TH, Soep HH, Thomis JA, Boelaert J, Daneels R, Dettli L. Should clearance be normalised to body surface or to lean body mass? Er J Clin Pharmacol. 1981;11:523-526. Letter.
23. Cobb LA, Weaver WD, Fahrenbruch CE, Hallstrom AP, Copass MK. Community-based interventions for sudden cardiac death: impact, limitations, and changes. Circulation. 1992;85(suppl I):I-98-I-102.
24. Roden DM, Hoffman BF. Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers: relationship to potassium and cycle length. Circ Res. 1985;56:857-867.
25. Lepeschkin E, Surawicz B. The duration of the Q-U interval and its components in electrocardiograms of normal persons. Am Heart J. 1953;46:9-20.
26. MacFarlane PW, Lawrie TDV. The normal electrocardiogram and vectorcardiogram. In: MacFarlane PW, Lawrie TDV, eds. Comprehensive Electrocardiology: Theory and Practice in Health and Disease. Elmsford, NY: Pergamon Press Inc; 1989;1:407-463.
27. Hashiba K. Hereditary QT prolongation syndrome in Japan: genetic analysis and pathological findings of the conducting system. Jpn Circ J. 1978;42:1133-1150.
28. Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, Hall WJ, Weitkamp L, Vincent GM, Garson A Jr, Robinson JL, Benhorin J, Choi S. The long QT syndrome: prospective longitudinal study of 328 families. Circulation. 1991;84:1136-1144.
29. Hashiba K. Sex differences in phenotypic manifestation and gene transmission in the Romano-Ward syndrome. Ann N Y Acad Sci. 1992;644;142-156.
30. Kawasaki R, Machado C, Reinoehl J, Fromm B, Baga JJ, Steinman RT, Lehmann MH. Increased propensity of women to develop torsades de pointes during complete heart block. J Cardiovasc Electrophysiol. 1995;6:1032-1038.
31. Lehmann MH, MacNeil DJ. Sex differences in magnitude of JTc prolongation with d,1-sotalol. Circulation. 1995;92(suppl I):I-277. Abstract.
32. Reinoehl J, Frankovich D, Machado C, Kawasaki R, Baga JJ, Pires LA, Steinman RT, Fromm B, Lehmann MH. Probucol-associated tachyarrhythmic events and QT prolongation: importance of gender. Am Heart J. 1996;131:1184-1191.
33. Rautaharju PM, Zhou SH, Wong S, Calhoun HP, Berenson GS, Prineas R, Davignon A. Sex differences in the evolution of the electro-cardiographic QT interval with age. Can J Cardiol 1992;8:690-695.
34. Lehmann MH, Timothy KW, Frankovich D, Fromm BS, Keating MA, Locati EH, Taggart RT, Towbin JA, Moss AJ, Schwartz PJ, Vincent GM. Age-sex influence on QTc and the QT-heart rate relationship in genotypically-characterized long QT syndrome families. J Am Coll Cardiol. In press.
35. Zareba W, Moss AJ, le Cessie S, Locati EH, Robinson JL, Hall WJ, Andrews ML. Risk of cardiac events in family members of patients with long QT syndrome. J Am Coll Cardiol. 1995;26:1685-1691.
36. Drici MD, Burklow TR, Haridasse V, Glazer RI, Woosley RL. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation. 1996;94:1471-1474.